尼古丁胺暴露后没有增加重大心血管事件的风险
Lee Wheless1,2,3, Ranya Guennoun4, Basia Michalski-McNeely4
1Tennessee Valley Healthcare System VA Medical Center, Vanderbilt University Medical Center.
medRxiv : the preprint server for health sciences
|October 7, 2024
概括
这项研究发现,在使用尼古丁胺胺的患者中,主要心血管事件 (MACE) 的风险没有增加. 之前的MACE史是未来事件的强有力的预测因素,而不是尼古丁胺使用.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 临床研究 临床研究
背景情况:
- 尼古丁胺胺代谢物被怀疑会增加主要心血管事件 (MACE) 的风险.
- 与尼古丁胺胺使用相关的MACE风险的临床数据有限.
研究的目的:
- 调查尼古丁胺使用与MACE发病率之间的关联.
- 提供关于尼古丁胺胺心血管安全性的临床证据.
主要方法:
- 追溯队列研究涉及6039名来自两个不同的队列 (VUMC和MVP) 的成年患者.
- 尼古丁胺胺暴露患者与未暴露患者的MACE风险比较.
- 用验证的MACE表型来评估结果.
主要成果:
- 在任何一个队列中,尼古丁胺胺暴露和MACE之间没有发现显著的关联.
- 之前的MACE史是后续MACE的强有力的预测因素.
- 对风险因素和混变量的调整没有改变研究结果.
结论:
- 在这项大型回顾性研究中,尼古丁胺胺暴露与MACE的风险增加无关.
- 这些发现表明尼古丁胺胺与较高的心血管事件率无关.
- 史 MACE 仍然是预测未来心血管事件的关键因素.
相关概念视频
Antianginal Drugs: Nitrates and β-Blockers
537
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
537
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
581
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
581
Myocarditis IV: Nursing Management
2
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
2
Antihypertensive Drugs: Vasodilators
490
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
490
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
462
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
462


